Drug Product
Analytical & Bioanalytical Services
Regulatory, Tech Transfer & Support Services
Company Overview
About
InnoSyn BV is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Biologics Manufacturing, Monoclonal Antibodies, Vaccines
Therapeutic Areas
Respiratory
Allergy
Quick Facts
HQ:Netherlands
Founded:2011
Employees:3,027
Capabilities & Services
Core Capabilities
- Biologics Drug Substance
- Biologics Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Sterile Injectable
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Pilot Scale
Phase I Clinical Trials
Clinical
Markets Served
Asia-Pacific
Regulatory Approvals
Drug Approval V4SN1I
EMA · #APR-XF6KEDFS · 2019-05-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-DGWVBJTF
Issued: 2020-01-27
Expires: 2025-07-09
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-IL6YZROP
Issued: 2020-06-22
Expires: 2025-12-28
WHO GMP
World Health Organization
Cert #: CERT-S9LU3N67
Issued: 2020-01-24
Expires: 2025-05-26
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-3NG254AJ
Issued: 2020-05-19
Expires: 2025-10-02
Loading CDMO intelligence...
Key facts about InnoSyn BV
- InnoSyn BV is headquartered in the Netherlands.
- InnoSyn BV was founded in 2011.
- InnoSyn BV has 3,027 employees.
- InnoSyn BV's capabilities include Biologics Drug Substance, Biologics Manufacturing and Formulation Development.
Find CDMOs like InnoSyn BV
Directory pages this company appears in, each with the full list of matching manufacturers.